Login
EN
[EN] English
[FR] Français
Login
EN
[EN] English
[FR] Français
Give us feedback
Explore
Search
Special collections
Statistics
News
Help
Start on ORBi
Deposit
Profile
Publication List
Add your ORCID
FAQ: FWB Open Access Decree
Tutorials
Legal Information
Training sessions
About
What's ORBi ?
Impact and visibility
Around ORBi
About statistics
About metrics
OAI-PMH
ORBi team
Release Notes
Back
Home
Novel RAS(ON) compounds overcome adaptive resistance to KRAS G12C inactive state inhibitors in lung adenocarcinoma - 2022
No full text
Unpublished conference/Abstract (Scientific congresses and symposiums)
Novel RAS(ON) compounds overcome adaptive resistance to KRAS G12C inactive state inhibitors in lung adenocarcinoma
Nokin, Marie-Julie
2022
•
GSK awards meeting
Permalink
https://hdl.handle.net/2268/332164
Files (0)
Send to
Details
Statistics
Bibliography
Similar publications
Files
Full Text
No document available.
Send to
RIS
BibTex
APA
Chicago
Permalink
X
Linkedin
copy to clipboard
copied
Details
Disciplines :
Oncology
Author, co-author :
Nokin, Marie-Julie
;
Université de Liège - ULiège > Département des sciences biomédicales et précliniques
Language :
English
Title :
Novel RAS(ON) compounds overcome adaptive resistance to KRAS G12C inactive state inhibitors in lung adenocarcinoma
Publication date :
25 May 2022
Event name :
GSK awards meeting
Event date :
25/05/2022
Available on ORBi :
since 22 May 2025
Statistics
Number of views
23 (0 by ULiège)
Number of downloads
0 (0 by ULiège)
More statistics
Bibliography
Similar publications
Contact ORBi
